Moreover, lncRNA PCA3 has been approved by FDA for clinical diagnosis of prostate cancer, so it is feasible to seek lncRNA in peripheral blood for diagnosis of HCC [28]. The gene discussed is PCA3; the disease is hepatocellular carcinoma.